Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
Johnson & Johnson received its third trial loss in a row over claims its talc powder can cause ovarian cancer after a St. Louis jury recently awarded nearly $70 million to a cancer patient. In a 9-3 vote, the jury awarded compensatory and punitive damages to 63-year-old Deborah Giannecchini, who said J&J’s talc powder caused her Stage IV ovarian cancer.
Improving orthopaedic care, education and research using Internet technologies